Professor Alsulaiman's research focuses on the development of advanced materials and nextgeneration platforms for minimally-invasive detection of disease biomarkers includingmicroRNA, proteins and other circulating biomarkers from ‘liquid biopsy’ biofluids. At theintersection between 2D materials, polymers and microtechnologies, her research includesadvancements in encoded hydrogel microparticles, enzyme-free electrochemical biosensorsand transdermal microneedles for drug delivery and biosensing. She is also interested insingle-molecule detection technologies, namely solid-state nanopore sensors, for the detectionand characterization of rare disease biomarkers. Dr Alsulaiman's research aims to tackleurgent clinical needs including early detection and monitoring of cancer andneurodegenerative diseases as well as developing accessible point-of-care platforms toenhance our pandemic preparedness and response. ​